Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Liver LDL receptor mRNA expression is decreased in human ApoB/CETP double transgenic mice and is regulated by diet as well as the cytokine oncostatin MJ Liu, Y L Zhang, M J Spence, et al.
Current Opinion in Lipidology|April 1, 1994
Transgenic mice expressing human apoB100 and apoB48S G Young, R V Farese, V R Pierotti, et al.
Journal of Lipid Research|May 1, 1995
Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humansD S Grass, U Saini, R H Felkner, et al.
The Journal of Clinical Investigation|May 15, 1996
Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrateD S Grass, R H Felkner, M Y Chiang, et al.
The Journal of Biological Chemistry|May 17, 1996
Transgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural geneS P McCormick, J K Ng, M Véniant, et al.
The Journal of Clinical Investigation|December 1, 1993
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)M F Linton, R V Farese, G Chiesa, et al.
Journal of Lipid Research|December 10, 1997
Secretory non-pancreatic phospholipase A2: influence on lipoprotein metabolismF C de Beer, M C de Beer, D R van der Westhuyzen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2B Ivandic, L W Castellani, X P Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipidsN Leitinger, A D Watson, S Y Hama, et al.
Pageof 2